Evaluation of the Quality of Life of Patients with DBB with the Installation of OPEP

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Feb 6, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how using a device called oscillating PEP (Positive Expiratory Pressure) can improve the quality of life for patients with bronchiectasis, a condition that affects the lungs. The study aims to see how this device helps both children (ages 8 and up) and adults who are stable and not currently experiencing severe symptoms. Researchers want to understand how using the oscillating PEP impacts daily life before and after its use.

To participate, individuals must be at least 8 years old and have been diagnosed with bronchiectasis but are not currently using the oscillating PEP device. Those who are not stable, are under 8 years old, or have other uncontrolled health issues won't be eligible. Participants can expect to be part of follow-up consultations where their quality of life will be assessed before and after using the device. This study is actively recruiting participants, and it’s a great opportunity for those looking to potentially improve their daily living with bronchiectasis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children (from 8 years of age) and adults over 18 years of age with DDB who doesn't use oscillating PEP.
• • The study population will be clinically stable and will be seen in follow-up consultations.
• Exclusion Criteria:
• • Children under 8 years of age.
• • Patients who use an OPEP
• • Patients in the acute exacerbation phase of their DDB
• • Patients who are not under regular consultation
• • Patients with severe, uncontrolled co-morbidities
• • Patients with cognitive or psychiatric disorders preventing proper adherence to the study protocol
• • Patients taking part simultaneously in another clinical study that could interfere with the results of the OPEP study